Myrtenal is a bicyclic monoterpenoid with the chemical formula C10H14O. It is a naturally occurring molecule that can be found in numerous plant species including Hyssopus officinalis, Salvia absconditiflora, and Cyperus articulatus.[1]
Names | |
---|---|
IUPAC name
6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde
| |
Other names
(1R)-2-Pinen-10-a
Benihinal | |
Identifiers | |
| |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.008.432 |
EC Number |
|
MeSH | myrtenal |
PubChem CID
|
|
UNII |
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C10H14O | |
Molar mass | 150.221 g·mol−1 |
Appearance | Colorless liquid |
Density | 0.987 g/cm3 |
Boiling point | 220-221 °C |
Hazards | |
GHS labelling: | |
Warning | |
H227 | |
P210, P280, P370 P378, P403 P235, P501 | |
Flash point | 78 °C |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Biological research
editMyrtenal was shown to inhibit acetylcholinesterase, which is a common method of treatment of alzheimer's disease and dementia, in-vitro.[2] In addition, mytenal has been shown to have antioxidant properties in rats.[3]
See also
editReferences
edit- ^ "LOTUS: Natural Products Online". lotus.naturalproducts.net. Retrieved 2022-08-17.
- ^ Kaufmann D, Dogra AK, Wink M (October 2011). "Myrtenal inhibits acetylcholinesterase, a known Alzheimer target". The Journal of Pharmacy and Pharmacology. 63 (10): 1368–1371. doi:10.1111/j.2042-7158.2011.01344.x. PMID 21899553. S2CID 44962827.1368-1371&rft.date=2011-10&rft_id=https://api.semanticscholar.org/CorpusID:44962827#id-name=S2CID&rft_id=info:pmid/21899553&rft_id=info:doi/10.1111/j.2042-7158.2011.01344.x&rft.aulast=Kaufmann&rft.aufirst=D&rft.au=Dogra, AK&rft.au=Wink, M&rfr_id=info:sid/en.wikipedia.org:Myrtenal" class="Z3988">
- ^ Lokeshkumar B, Sathishkumar V, Nandakumar N, Rengarajan T, Madankumar A, Balasubramanian MP (September 2015). "Anti-Oxidative Effect of Myrtenal in Prevention and Treatment of Colon Cancer Induced by 1, 2-Dimethyl Hydrazine (DMH) in Experimental Animals". Biomolecules & Therapeutics. 23 (5): 471–478. doi:10.4062/biomolther.2015.039. PMC 4556208. PMID 26336588.471-478&rft.date=2015-09&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556208#id-name=PMC&rft_id=info:pmid/26336588&rft_id=info:doi/10.4062/biomolther.2015.039&rft.aulast=Lokeshkumar&rft.aufirst=B&rft.au=Sathishkumar, V&rft.au=Nandakumar, N&rft.au=Rengarajan, T&rft.au=Madankumar, A&rft.au=Balasubramanian, MP&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556208&rfr_id=info:sid/en.wikipedia.org:Myrtenal" class="Z3988">